BIOSYM A/S: Financial statements 2017
CVR: 21774189
Source: annual report 2017, Danish Business Authority
01/07/2016 – 30/06/2017
BIOSYM A/S (CVR 21774189) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 11,640,256 and a net result of DKK 2,844,575 compared with DKK 5,604,542 the year before. That is a decrease of 16.6% compared with the year before. Equity in the 2017 report amounted to DKK 12,501,884. The solvency ratio was 64.2%. The company had 17 employees in the financial year.
- Gross Profit
- DKK 11,640,256
- Profit/Loss
- DKK 2,844,575
- Equity
- DKK 12,501,884
- Total Assets
- DKK 19,459,950
- Employees
- 17
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 11.6 mio. | 2.8 mio. | 12.5 mio. | 17 |
| 2016 | - | 14 mio. | 5.6 mio. | 15.2 mio. | - |
| 2015 | - | 7.6 mio. | 2 mio. | 9.6 mio. | - |
| 2014 | - | 6.1 mio. | 1.5 mio. | 7.6 mio. | - |
| 2013 | - | -4.7 mio. | 555 t. | -6 mio. | - |
Official annual report
Keep an eye on BIOSYM A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout BIOSYM A/S
BIOSYM A/S is a Danish company of the type Aktieselskab based in Ikast, founded in 1999. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Sanne Biisgaard. The board consists of Kati Marika Rajala (chair), Elina Liisa Maarit Haavisto and Janne Vertanen. The company is owned by Oy Verman Ab. The company has 21 employees (2018). In 2025, the company reported a gross profit of DKK 23,552,721 and a net result of DKK 8,530,373 compared with DKK 3,810,817 the year before. Equity in the 2025 report amounted to DKK 46,311,564.